| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| I A Prescott, L D Liu, J O Dostrovsky, M Hodaie, A M Lozano, W D Hutchiso. Lack of depotentiation at basal ganglia output neurons in PD patients with levodopa-induced dyskinesia. Neurobiology of disease. vol 71. 2015-06-02. PMID:25116960. |
parkinson's disease (pd), characterized by the loss of dopaminergic nigrostriatal projections, is a debilitating neurodegenerative disease which produces bradykinesia, rigidity, tremor and postural instability. |
2015-06-02 |
2023-08-13 |
Not clear |
| Andrew Agbay, Nima Khadem Mohtaram, Stephanie Michelle Willert. Controlled release of glial cell line-derived neurotrophic factor from poly(ε-caprolactone) microspheres. Drug delivery and translational research. vol 4. issue 2. 2015-05-08. PMID:25786730. |
glial cell line-derived neurotrophic factor (gdnf), a growth factor expressed in the central nervous system, promotes the survival of both dopaminergic and motor neurons, making it a promising candidate for neurodegenerative disease therapy. |
2015-05-08 |
2023-08-13 |
cattle |
| Bo M Morberg, Joakim Jensen, Matthias Bode, Lene Wermut. The impact of high intensity physical training on motor and non-motor symptoms in patients with Parkinson's disease (PIP): a preliminary study. NeuroRehabilitation. vol 35. issue 2. 2015-04-17. PMID:24990028. |
parkinson's disease (pd) is a neurodegenerative disease caused by loss of dopaminergic nigrostriatal neurons. |
2015-04-17 |
2023-08-13 |
Not clear |
| Sandra A Acosta, Naoki Tajiri, Ike de la Pena, Marina Bastawrous, Paul R Sanberg, Yuji Kaneko, Cesar V Borlonga. Alpha-synuclein as a pathological link between chronic traumatic brain injury and Parkinson's disease. Journal of cellular physiology. vol 230. issue 5. 2015-04-10. PMID:25251017. |
notably, tbi may predispose long-term survivors to age-related neurodegenerative diseases, such as parkinson's disease (pd), which is characterized by a gradual degeneration of the nigrostriatal dopaminergic neurons. |
2015-04-10 |
2023-08-13 |
rat |
| Judith Eschbach, Karin M Danze. α-Synuclein in Parkinson's disease: pathogenic function and translation into animal models. Neuro-degenerative diseases. vol 14. issue 1. 2015-02-12. PMID:24080741. |
parkinson's disease is a common neurodegenerative disease characterised by the loss of dopaminergic neurons in the substantia nigra pars compacta and the formation of α-synuclein aggregates found in lewy bodies throughout the brain. |
2015-02-12 |
2023-08-12 |
mouse |
| Karl Grenier, Maria Kontogiannea, Edward A Fo. Short mitochondrial ARF triggers Parkin/PINK1-dependent mitophagy. The Journal of biological chemistry. vol 289. issue 43. 2015-02-12. PMID:25217637. |
parkinson disease (pd) is a complex neurodegenerative disease characterized by the loss of dopaminergic neurons in the substantia nigra. |
2015-02-12 |
2023-08-13 |
Not clear |
| Vannary Tieng, Luc Stoppini, Sabrina Villy, Marc Fathi, Michel Dubois-Dauphin, Karl-Heinz Kraus. Engineering of midbrain organoids containing long-lived dopaminergic neurons. Stem cells and development. vol 23. issue 13. 2015-02-05. PMID:24576173. |
the possibility to generate dopaminergic (da) neurons from pluripotent stem cells represents an unlimited source of material for tissue engineering and cell therapy for neurodegenerative disease. |
2015-02-05 |
2023-08-12 |
Not clear |
| Chien-Wei Feng, Zhi-Hong Wen, Shi-Ying Huang, Han-Chun Hung, Chun-Hong Chen, San-Nan Yang, Nan-Fu Chen, Hui-Min Wang, Chung-Der Hsiao, Wu-Fu Che. Effects of 6-hydroxydopamine exposure on motor activity and biochemical expression in zebrafish (Danio rerio) larvae. Zebrafish. vol 11. issue 3. 2015-02-04. PMID:24720843. |
parkinson's disease (pd) is a neurodegenerative disease that is characterized by the progressive loss of dopaminergic (da) neurons in the substantia nigra. |
2015-02-04 |
2023-08-13 |
zebrafish |
| Natasa Kustrimovic, Emanuela Rasini, Massimiliano Legnaro, Franca Marino, Marco Cosentin. Expression of dopaminergic receptors on human CD4+ T lymphocytes: flow cytometric analysis of naive and memory subsets and relevance for the neuroimmunology of neurodegenerative disease. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology. vol 9. issue 3. 2015-01-26. PMID:24682738. |
expression of dopaminergic receptors on human cd4+ t lymphocytes: flow cytometric analysis of naive and memory subsets and relevance for the neuroimmunology of neurodegenerative disease. |
2015-01-26 |
2023-08-12 |
human |
| Jesse V Veenvliet, Marten P Smid. Molecular mechanisms of dopaminergic subset specification: fundamental aspects and clinical perspectives. Cellular and molecular life sciences : CMLS. vol 71. issue 24. 2015-01-26. PMID:25064061. |
dopaminergic (da) neurons in the ventral mesodiencephalon control locomotion and emotion and are affected in psychiatric and neurodegenerative diseases, such as parkinson's disease (pd). |
2015-01-26 |
2023-08-13 |
Not clear |
| Min Zhu, Wen-Wei Li, Chuan-Zhen L. Histone decacetylase inhibitors prevent mitochondrial fragmentation and elicit early neuroprotection against MPP+. CNS neuroscience & therapeutics. vol 20. issue 4. 2014-12-09. PMID:24351065. |
parkinson's disease (pd) is a common neurodegenerative disease, characterized by progressive loss of dopaminergic (da) neurons in the substantia nigra. |
2014-12-09 |
2023-08-12 |
Not clear |
| Xiaoying Wang, Guiyun Cui, Xinxin Yang, Zunsheng Zhang, Hongjuan Shi, Jie Zu, Fang Hua, Xia She. Intracerebral administration of ultrasound-induced dissolution of lipid-coated GDNF microbubbles provides neuroprotection in a rat model of Parkinson's disease. Brain research bulletin. vol 103. 2014-12-03. PMID:24583079. |
parkinson's disease (pd) is a neurodegenerative disease characterized by loss of dopaminergic neurons in the substantia nigra. |
2014-12-03 |
2023-08-12 |
rat |
| Xiu-Qi Bao, Xiang-Chen Kong, Li-Bing Kong, Liang-Yu Wu, Hua Sun, Dan Zhan. Squamosamide derivative FLZ protected dopaminergic neuron by activating Akt signaling pathway in 6-OHDA-induced in vivo and in vitro Parkinson's disease models. Brain research. vol 1547. 2014-09-15. PMID:24384139. |
parkinson's disease (pd) is a neurodegenerative disease affecting up to 80% of dopaminergic neurons in the nigrostriatal pathway. |
2014-09-15 |
2023-08-12 |
rat |
| Eun Hee Ahn, Dae Won Kim, Min Jea Shin, Young Nam Kim, Hye Ri Kim, Su Jung Woo, So Mi Kim, Duk-Soo Kim, Joon Kim, Jinseu Park, Won Sik Eum, Hyun Sook Hwang, Soo Young Cho. PEP-1-ribosomal protein S3 protects dopaminergic neurons in an MPTP-induced Parkinson's disease mouse model. Free radical biology & medicine. vol 55. 2014-08-20. PMID:23178948. |
parkinson's disease (pd) is a neurodegenerative disease characterized by a gradual loss of dopaminergic (da) neurons in the substantia nigra (sn) of the brain. |
2014-08-20 |
2023-08-12 |
mouse |
| Theresa A Zesiewicz, Pablo Martinez-Marti. Effects of rotigotine transdermal system on non-motor symptoms in Parkinson's disease: an overview. Expert review of neurotherapeutics. vol 13. issue 12. 2014-08-06. PMID:24236902. |
parkinson's disease (pd) is a progressive neurodegenerative disease, involving the dopaminergic, noradrenergic, serotonergic and cholinergic systems. |
2014-08-06 |
2023-08-12 |
Not clear |
| Saeed Esmaeili-Mahani, Somayeh Vazifekhah, Hamzeh Pasban-Aliabadi, Mehdi Abbasnejad, Vahid Sheiban. Protective effect of orexin-A on 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y human dopaminergic neuroblastoma cells. Neurochemistry international. vol 63. issue 8. 2014-07-22. PMID:24135219. |
parkinson's disease (pd) is a progressive neurodegenerative disease characterized by progressive and selective death of midbrain dopaminergic neurons. |
2014-07-22 |
2023-08-12 |
human |
| Sabrina M Heman-Ackah, Martina Hallegger, Mahendra S Rao, Matthew J A Woo. RISC in PD: the impact of microRNAs in Parkinson's disease cellular and molecular pathogenesis. Frontiers in molecular neuroscience. vol 6. 2014-06-24. PMID:24312000. |
parkinson's disease (pd) is a debilitating neurodegenerative disease characterized primarily by the selective death of dopaminergic (da) neurons in the substantia nigra pars compacta of the midbrain. |
2014-06-24 |
2023-08-12 |
Not clear |
| Genaro Gabriel Ortiz, Fermín P Pacheco-Moisés, Víctor M Gómez-Rodríguez, Erika D González-Renovato, Erandhis D Torres-Sánchez, Ana C Ramírez-Anguian. Fish oil, melatonin and vitamin E attenuates midbrain cyclooxygenase-2 activity and oxidative stress after the administration of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine. Metabolic brain disease. vol 28. issue 4. 2014-06-20. PMID:23703110. |
parkinson's disease is a neurodegenerative disease whose hallmark pathological features include a selective loss of dopaminergic neurons in the midbrain. |
2014-06-20 |
2023-08-12 |
mouse |
| Shane V Hegarty, Aideen M Sullivan, Gerard W O'Keeff. BMP2 and GDF5 induce neuronal differentiation through a Smad dependant pathway in a model of human midbrain dopaminergic neurons. Molecular and cellular neurosciences. vol 56. 2014-06-20. PMID:23831389. |
parkinson's disease is the second most common neurodegenerative disease, and is characterised by the progressive degeneration of the nigrostriatal dopaminergic (da) system. |
2014-06-20 |
2023-08-12 |
human |
| Xian-Ming Luo, Hai Lin, Wei Wang, Marilyn S Geaney, Lee Law, Shaun Wynyard, Shamim B Shaikh, Henry Waldvogel, Richard L M Faull, Robert B Elliott, Stephen J M Skinner, Jacqueline E Lee, Paul L-J Ta. Recovery of neurological functions in non-human primate model of Parkinson's disease by transplantation of encapsulated neonatal porcine choroid plexus cells. Journal of Parkinson's disease. vol 3. issue 3. 2014-06-17. PMID:24002224. |
parkinson's disease (pd) is a neurodegenerative disease that is primarily characterized by degeneration of dopaminergic (da) neurons in the substantia nigra (sn) and a loss of their fibre projections in the striatum. |
2014-06-17 |
2023-08-12 |
monkey |